DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Targan SR, Feagan BG, Fedorak RN et al.
International Efficacy of Natalizumab in Crohn’s Disease Response and Remission (ENCORE) Trial Group. Natalizumab for the treatment of active Crohn’s disease: results of the ENCORE Trial.
Gastroenterology 2007;
132: 1672-1683
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.